Menu
Log in

AFT extends e-commerce presence into Amazon US

15 Jul 2023 3:05 PM | Mike Hearn (Administrator)

AFT Pharmaceuticals (ASX: AFP, NZX: AFT) announces an extension of its global ecommerce strategy with the launch of online stores on Amazon in the US and Australia.

The new AFT Pharmaceuticals-branded stores on the North American-facing https://www.amazon.com/AFTPharmaceuticals and the Australian facing https://www.amazon.com.au/AFTPharmaceuticals sites complement and build on AFT’s global e-commerce strategy.

This includes a Tmall site through which AFT sells into China using the cross-border ecommerce platform https://kiwihealthbjp.tmall.hk/ , and the broad online presence we already enjoy in Australia with our own AFT Pharm website shop https://nzshop.aftpharm.com/. The Australian site also supports our extensive distribution network through pharmacies, medical practices and hospitals https://aushop.aftpharm.com/.

AFT has been working with Sell Global, a specialist Amazon agency, to launch on Amazon USA and Australia. The project so far has included researching the market opportunity, understanding the compliance requirements for imports, setting up quality product listings and brand presence, and now advertising and promoting on Amazon.

The US and Australian Amazon sites will initially carry AFT’s trusted portfolio of Liposomal vitamins, but additional launches of other products are planned for the Australian store in the coming months and the North American site after the initial launch is satisfactorily completed.

The products, which will be available for US, Canadian, and Australian customers, include Vitamin C LipoSachet®, Vitamin C LipoSachet® for Kids, Vitamin D LipoSachet®, and Ferro (Iron) LipoSachet®.

AFT Pharmaceuticals Founder and Managing Director Dr Hartley Atkinson said: “The Amazon AFT Pharmaceuticals e-commerce store aims to leverage off the existing strong awareness of Liposomal vitamins in the US. To date this interest has mainly centred around liposomal Vitamin C but AFT will also include both Vitamin D and Iron forms of liposomal vitamins.

“The products offer a further growth opportunity for AFT’s international business unit. The US is the world’s largest market for nutritional supplements and is growing rapidly. The North America dietary supplements market size was valued at over USD50 billion  in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 5.6% from 2021 to 2028”
Dr Atkinson said.

“Building our online presence is a further element of our strategy to extend AFT’s reach around the world. It builds on the strong growth we are seeing in the Australasian business, which is being fuelled by growth from existing products and a planned 68 new product launches through until the end of FY26.

“Our ecommerce presence enhances our brand recognitions in key markets enabling us to make our products readily accessible to consumers globally.

“We also see further potential to expand our online presence. Notably, in China we are also working to further build and evolve our existing on-line cross border ecommerce presence through both additional products and e-commerce platforms.

“These growth initiatives will also be supported by products emerging from our extensive research and development pipeline.” We have also expanded our operational hubs in Singapore and Malaysia to include Hong Kong and the United Kingdom. This will allow us to add selected products from our new and existing Australasian pipeline to these additional markets” Dr Atkinson said.

Source: https://investors.aftpharm.com/


   © American Chamber of Commerce in New Zealand Inc  •  Site by HighlandCreative.com.au